Daniel Devine & Co’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Daniel Devine & Co's XBI Position: Q2 2018 in Review
Daniel Devine & Co increased its State Street SPDR S&P Biotech ETF (XBI) stake by 17% in Q2 2018, buying an estimated $101K and bringing the position to 7,400 shares worth $704K. The position accounts for 0.56% of the portfolio, ranked #36.
Daniel Devine & Co first reported a position in XBI in Q1 2018 and has held it in 2 quarters since. 431 funds tracked by Wall St. Rank hold XBI as of Q2 2018.
- Daniel Devine & Co held 7,400 shares of State Street SPDR S&P Biotech ETF worth $704K as of Q2 2018.
- Daniel Devine & Co bought 1,100 State Street SPDR S&P Biotech ETF shares in Q2 2018, an estimated $101K.
- State Street SPDR S&P Biotech ETF made up 0.56% of Daniel Devine & Co's portfolio in Q2 2018, its #36 holding.
- Daniel Devine & Co first reported a position in State Street SPDR S&P Biotech ETF in Q1 2018 and has held it in 2 quarters since.
- 431 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2018.
Based on Daniel Devine & Co's 13F filing for Q2 2018, filed 18 Jul 2018.